At the June 5-6, 2023 meeting, the Board is scheduled to receive the Executive Director's report and engage in a strategy discussion about advancing PCORI's comparative clinical effectiveness research (CER) portfolio. The Board is also expected to consider for approval new funding to advance several topic themes, among other business. View the agenda for more details.

All PCORI Board meetings are open to the public. Members of the public are invited to join this meeting, which will take place in Washington, DC, via teleconference/webinar.

Registration is required. Click on the buttons to register.

June 5: Register June 6: Register

Meeting Materials

Public Comment Period

This meeting will include a public comment period on Tuesday, June 6, from 3:15 - 3:45pm ET. Registration^ is required to provide comments via telephone. (Guidelines for Public Comments) (Technical Guidance for Commenters).

Register to Provide Comment

Catch up on past PCORI Board meetings here.

*Meeting agendas are subject to change.

^Please note that after you sign up to provide comment at this meeting, you will receive a confirmation email from PCORI about your registration. Please check your spam folder for this email if you don’t receive it, and reply to the email to confirm your intention to make a public comment.


Location Type